GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer

2789.4000 -12.70 (-0.45%)

NSE Aug 26, 2025 15:31 PM

45.21% Gain from 52W Low

Volume: 180.3K

GlaxoSmithKline Pharmaceuticals Ltd.

25 Aug 2025

2789.40

-0.45%

Company Update

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Company forays into Oncology with Jemperli & Zejula , bringing precisions therapies for Gynaecological Cancers

More from GlaxoSmithKline Pharmaceuticals Ltd.

Recommended

Market closes lower, Minister of State for Communications denies relief for Vodafone Idea

Trendlyne Marketwatch | 26 Aug 2025, 04:06PM

IPO activity surges with ten new issues and ten listings this week

Five Interesting Stocks Today - August 22, 2025

The Baseline | 22 Aug 2025